GLP2R anticorps (N-Term)
-
- Antigène Voir toutes GLP2R Anticorps
- GLP2R (Glucagon-Like Peptide 2 Receptor (GLP2R))
-
Épitope
- N-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp GLP2R est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- GLP2 R antibody was raised against the N terminal of GLP2
- Purification
- Affinity purified
- Immunogène
- GLP2 R antibody was raised using the N terminal of GLP2 corresponding to a region with amino acids KLGSSRAGPGRGSAGLLPGVHELPMGIPAPWGTSPLSFHRKCSLWAPGRP
- Top Product
- Discover our top product GLP2R Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
GLP2R Blocking Peptide, catalog no. 33R-4510, is also available for use as a blocking control in assays to test for specificity of this GLP2R antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GLP0 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- GLP2R (Glucagon-Like Peptide 2 Receptor (GLP2R))
- Autre désignation
- GLP2R (GLP2R Produits)
- Synonymes
- anticorps 9530092J08Rik, anticorps GLP-2, anticorps glucagon like peptide 2 receptor, anticorps glucagon-like peptide 2 receptor, anticorps GLP2R, anticorps Glp2r
- Sujet
- The GLP2 receptor (GLP2R) is a G protein-coupled receptor superfamily member closely related to the glucagon receptor ans GLP1 receptor. Glucagon-like peptide-2 (GLP2) is a 33-amino acid proglucagon-derived peptide produced by intestinal enteroendocrine cells. Like glucagon-like peptide-1 (GLP1) and glucagon itself, it is derived from the proglucagon peptide encoded by the GCG gene. GLP2 stimulates intestinal growth and upregulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. Moreover, GLP2 prevents intestinal hypoplasia resulting from total parenteral nutrition.
- Poids moléculaire
- 61 kDa (MW of target protein)
- Pathways
- Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, cAMP Metabolic Process, Feeding Behaviour
-